In our analysis, we found that high ABCC2 mRNA expression was significantly associated with reduced PPS in all ovarian cancer and HGSOC, but we did not find any relationship between patient outcome and ABCC2 protein expression. The gene discussed is ABCC2; the disease is ovarian cancer.